Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17855016rdf:typepubmed:Citationlld:pubmed
pubmed-article:17855016lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C0024881lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C1306673lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C0600558lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:17855016lifeskim:mentionsumls-concept:C0580836lld:lifeskim
pubmed-article:17855016pubmed:issue5lld:pubmed
pubmed-article:17855016pubmed:dateCreated2007-11-23lld:pubmed
pubmed-article:17855016pubmed:abstractTextPostmastectomy radiotherapy (PMRT) improves locoregional control (LRC) in patients with high-risk features after mastectomy. Young age continues to evolve as a potentially important risk factor. The objective of this study was to assess the benefits of PMRT in patients <35 years old treated with doxorubicin-based neoadjuvant chemotherapy for Stage II-III breast cancer.lld:pubmed
pubmed-article:17855016pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17855016pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17855016pubmed:languageenglld:pubmed
pubmed-article:17855016pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17855016pubmed:citationSubsetIMlld:pubmed
pubmed-article:17855016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17855016pubmed:statusMEDLINElld:pubmed
pubmed-article:17855016pubmed:monthDeclld:pubmed
pubmed-article:17855016pubmed:issn0360-3016lld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:BuchholzThoma...lld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:StromEric AEAlld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:HuangEugeneElld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:PerkinsGeorge...lld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:GargAmit KAKlld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:Meric-Bernsta...lld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:WoodwardWendy...lld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:OswaldMary...lld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:OhJulia LJLlld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:TereffeWelela...lld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:YuT KuanTKlld:pubmed
pubmed-article:17855016pubmed:authorpubmed-author:HahnKarinKlld:pubmed
pubmed-article:17855016pubmed:issnTypePrintlld:pubmed
pubmed-article:17855016pubmed:day1lld:pubmed
pubmed-article:17855016pubmed:volume69lld:pubmed
pubmed-article:17855016pubmed:ownerNLMlld:pubmed
pubmed-article:17855016pubmed:authorsCompleteYlld:pubmed
pubmed-article:17855016pubmed:pagination1478-83lld:pubmed
pubmed-article:17855016pubmed:dateRevised2011-6-6lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:meshHeadingpubmed-meshheading:17855016...lld:pubmed
pubmed-article:17855016pubmed:year2007lld:pubmed
pubmed-article:17855016pubmed:articleTitleEffect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.lld:pubmed
pubmed-article:17855016pubmed:affiliationDepartment of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.lld:pubmed
pubmed-article:17855016pubmed:publicationTypeJournal Articlelld:pubmed